Covidien gets FDA OK for patient monitoring device

08/1/2012 |

The FDA has given Covidien 510(k) clearance for its Nellcor Bedside SpO2 Patient Monitoring System, which features the firm's OxiMax technology. The device, which is used to track pulse rate and SpO2 in children and adults, provides clinicians with access to a patient's respiratory records.

View Full Article in:

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX